{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dyslipidemia%2C+Renal+Insufficiency", "query": { "condition": "Dyslipidemia, Renal Insufficiency" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dyslipidemia%2C+Renal+Insufficiency&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T06:13:12.418Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06374277", "title": "Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes", "Hypertension", "High Cholesterol/Hyperlipidemia", "Coronary Artery Disease", "Congestive Heart Failure", "Chronic Lung Disease", "Chronic Kidney Diseases", "Arrythmia", "Stroke", "Depression", "Anxiety", "Pulmonary Embolism", "Heart Attack" ], "interventions": [ { "name": "Med AAAction intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Tennessee", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 388, "start_date": "2024-04-06", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 2, "location_summary": "Knoxville, Tennessee • Memphis, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06374277" }, { "nct_id": "NCT00108485", "title": "Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2", "Kidney Failure, Chronic", "Hyperlipidemia" ], "interventions": [ { "name": "Extended release niacin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2005-04", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00108485" }, { "nct_id": "NCT05934292", "title": "Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolaemia" ], "interventions": [ { "name": "Enlicitide Decanoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 33, "start_date": "2023-07-20", "completion_date": "2024-01-19", "has_results": true, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 5, "location_summary": "Hallandale, Florida • Miami, Florida • Orlando, Florida + 1 more", "locations": [ { "city": "Hallandale", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05934292" }, { "nct_id": "NCT02275156", "title": "Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperlipidemia", "Mixed Dyslipidemia" ], "interventions": [ { "name": "Evolocumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 18, "start_date": "2014-08-19", "completion_date": "2014-12-19", "has_results": true, "last_update_posted_date": "2022-11-07", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02275156" }, { "nct_id": "NCT00585143", "title": "Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dyslipidemia, Renal Insufficiency" ], "interventions": [ { "name": "ABT-335", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 37, "start_date": "2008-01", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2012-09-28", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 6, "location_summary": "Gainesville, Florida • Miami, Florida • Minneapolis, Minnesota + 3 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Knoxville", "state": "Tennessee" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00585143" }, { "nct_id": "NCT02341664", "title": "Patient and Provider Assessment of Lipid Management Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hyperlipidemia", "Hypercholesterolemia", "Cardiovascular Disease", "Diabetes", "Chronic Kidney Disease (CKD)", "Hypertension", "Smoking", "Myocardial Infarction (MI)", "Unstable Angina", "Angina", "Coronary Artery Disease (CAD)", "Stroke", "Transient Ischemic Attack (TIA)", "Carotid Stenosis", "Peripheral Arterial Disease", "Atherosclerosis", "Claudication" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7658, "start_date": "2015-05", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • San Pedro, California • Ventura, California + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Pedro", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah Gardens", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02341664" }, { "nct_id": "NCT04306939", "title": "Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pancreatitis", "Inflammatory Bowel Diseases", "Hepatitis", "NASH - Nonalcoholic Steatohepatitis", "Acute Pancreatitis", "Rheumatoid Arthritis", "Diabetes Mellitus", "Dyslipidemias", "Multiple Sclerosis", "Irritable Bowel Syndrome", "Chronic Pain", "Chronic Disease", "Chronic Kidney Diseases", "Crohn Disease", "Celiac Disease", "Biliary Cirrhosis", "Bile Acid Synthesis Defect", "Gastritis", "Cholecystitis", "Cholelithiases", "IPMN", "Cyst Pancreas", "Cystic Fibrosis", "Pancreatic Exocrine Insufficiency", "Diarrhea Chronic", "Constipation - Functional", "Constipation Chronic Idiopathic" ], "interventions": [ { "name": "venipuncture", "type": "OTHER" }, { "name": "Questionnaires", "type": "BEHAVIORAL" }, { "name": "Additional Sample Collections", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 120000, "start_date": "2014-11-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04306939" }, { "nct_id": "NCT04510844", "title": "Evolocumab In Advanced Chronic Kidney Disease Trial", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Diseases", "High Cholesterol" ], "interventions": [ { "name": "Evolocumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2021-03-01", "completion_date": "2021-10-01", "has_results": false, "last_update_posted_date": "2022-07-28", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 2, "location_summary": "Mineola, New York • New York, New York", "locations": [ { "city": "Mineola", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04510844" }, { "nct_id": "NCT07654231", "title": "Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease Mineral and Bone Disorder", "Hypertension", "Diabetes", "Dyslipidemia", "Atherosclerotic Cardiovascular Disease (ASCVD)", "Chronic Kidney Disease (Stage 3)" ], "interventions": [ { "name": "Low-dose Colchicine at 0.5mg daily", "type": "DRUG" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 60, "start_date": "2026-07-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07654231" }, { "nct_id": "NCT07209527", "title": "Truway Diagnostic Tools in Primary Care", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Chronic Disease", "Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight", "Hypertension", "Cardiovascular Disease Acute", "Hyperlipidemia", "Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD", "Peripheral Artery Disease", "Metabolic Syndrome", "Prediabetes" ], "interventions": [ { "name": "Truway Portable Ultrasound Device", "type": "DEVICE" }, { "name": "Truway Blood Glucose Monitor", "type": "DEVICE" }, { "name": "Standard Oral Hypoglycemic Agent", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Truway Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2025-10-01", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-10-04T06:13:12.418Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07209527" } ] }